BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37436761)

  • 1. Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans.
    Wolfgang AS; Hoge CW
    JAMA Psychiatry; 2023 Sep; 80(9):869-870. PubMed ID: 37436761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and effects of cannabinoids in military veterans with posttraumatic stress disorder.
    Betthauser K; Pilz J; Vollmer LE
    Am J Health Syst Pharm; 2015 Aug; 72(15):1279-84. PubMed ID: 26195653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans.
    Santangelo O; Baldwin JM; Stogner J
    Int J Drug Policy; 2022 Aug; 106():103756. PubMed ID: 35738030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders.
    Cohen J; Wei Z; Phang J; Laprairie RB; Zhang Y
    J Clin Neurophysiol; 2020 Jan; 37(1):28-34. PubMed ID: 31895187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of the Clinical Effects of Cannabis and Cannabinoids in Posttraumatic Stress Disorder Symptoms and Symptom Clusters.
    Rodas JD; George TP; Hassan AN
    J Clin Psychiatry; 2024 Feb; 85(1):. PubMed ID: 38353645
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
    Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion.
    Krediet E; Janssen DG; Heerdink ER; Egberts TC; Vermetten E
    Eur Neuropsychopharmacol; 2020 Jul; 36():244-254. PubMed ID: 32576481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis therapy.
    Kowalski JT
    Dtsch Arztebl Int; 2013 Mar; 110(9):144. PubMed ID: 23533556
    [No Abstract]   [Full Text] [Related]  

  • 9. Cannabis therapy.
    Müller-Vahl K; Grotenhermen F
    Dtsch Arztebl Int; 2013 Mar; 110(9):144. PubMed ID: 23533555
    [No Abstract]   [Full Text] [Related]  

  • 10. Brief report: Synthetic cannabinoid use among military personnel.
    Stogner J; Santangelo O; Baldwin JM
    Am J Addict; 2024 Jan; 33(1):96-99. PubMed ID: 37717217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder.
    Bonn-Miller MO; Vujanovic AA; Drescher KD
    Psychol Addict Behav; 2011 Sep; 25(3):485-91. PubMed ID: 21261407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational therapy for military personnel and military veterans experiencing post-traumatic stress disorder: A scoping review.
    Kerr NC; Ashby S; Gerardi SM; Lane SJ
    Aust Occup Ther J; 2020 Oct; 67(5):479-497. PubMed ID: 32627215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttraumatic stress disorder in veterans and military personnel: epidemiology, screening, and case recognition.
    Gates MA; Holowka DW; Vasterling JJ; Keane TM; Marx BP; Rosen RC
    Psychol Serv; 2012 Nov; 9(4):361-382. PubMed ID: 23148803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Posttraumatic Stress Disorder and Sexual Difficulties: A Systematic Review of Veterans and Military Personnel.
    Bird ER; Piccirillo M; Garcia N; Blais R; Campbell S
    J Sex Med; 2021 Aug; 18(8):1398-1426. PubMed ID: 34257051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
    Solmi M; De Toffol M; Kim JY; Choi MJ; Stubbs B; Thompson T; Firth J; Miola A; Croatto G; Baggio F; Michelon S; Ballan L; Gerdle B; Monaco F; Simonato P; Scocco P; Ricca V; Castellini G; Fornaro M; Murru A; Vieta E; Fusar-Poli P; Barbui C; Ioannidis JPA; Carvalho AF; Radua J; Correll CU; Cortese S; Murray RM; Castle D; Shin JI; Dragioti E
    BMJ; 2023 Aug; 382():e072348. PubMed ID: 37648266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention.
    Mizrachi Zer-Aviv T; Segev A; Akirav I
    Behav Pharmacol; 2016 Oct; 27(7):561-9. PubMed ID: 27551883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massed versus standard prolonged exposure for posttraumatic stress disorder in Australian military and veteran populations (RESTORE trial): Study protocol for a non-inferiority randomized controlled trial.
    Dell L; Sbisa AM; O'Donnell M; Tuerk PW; Bryant R; Hodson S; Morton D; Battersby M; Forbes A; Forbes D
    Contemp Clin Trials; 2021 Aug; 107():106478. PubMed ID: 34119717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological treatment for military posttraumatic stress disorder: an integrative review.
    Tawa J; Murphy S
    J Am Assoc Nurse Pract; 2013 Aug; 25(8):419-423. PubMed ID: 24170638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Answering the call to address chronic pain in military service members and veterans: Progress in improving pain care and restoring health.
    Schoneboom BA; Perry SM; Barnhill WK; Giordano NA; Wiltse Nicely KL; Polomano RC
    Nurs Outlook; 2016; 64(5):459-84. PubMed ID: 27427406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid interventions for PTSD: Where to next?
    Ney LJ; Matthews A; Bruno R; Felmingham KL
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():124-140. PubMed ID: 30946942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.